Rocket Pharmaceuticals (RCKT) Tops Q3 EPS by 4c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Activist investors push Seer, Inc. to disclose go-private timeline
• Active options: NFLX HTZ MSTR NBIS PLTR SNDK CRWV MSFT ONDS ORCL CSCO
• Ideal Power (IPWR) Tops Q2 EPS by 2c